DRUG · Unmapped registry intervention
Met DR
Find medicine records ·
Find other trials using this name
Clinical trial
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
NCT02526524
Study summary
ClinicalTrials.govDose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Met IR
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Advertisement
Conditions
Interventions
Sponsors & collaborators
Elcelyx Therapeutics, Inc.lead sponsor
Mapped research locations
HoustonTexas, United States4Las VegasNevada, United States4DallasTexas, United States3MiamiFlorida, United States3San AntonioTexas, United States3BirminghamAlabama, United States3CincinnatiOhio, United States3SacramentoCalifornia, United States3TampaFlorida, United States2PhoenixArizona, United States2OmahaNebraska, United States2AlbuquerqueNew Mexico, United States2
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02526524 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.